financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
Insmed's Lung Disease Drug Meets Primary Endpoint in Late-Stage Study -- Shares Surge Premarket
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Insmed's Lung Disease Drug Meets Primary Endpoint in Late-Stage Study -- Shares Surge Premarket
May 28, 2024 4:44 AM

07:15 AM EDT, 05/28/2024 (MT Newswires) -- Insmed ( INSM ) said Tuesday that its experimental drug, brensocatib, for the treatment of bronchiectasis lung disease, has met the primary endpoint in a late-stage study.

The company said brensocatib was statistically significant in reducing the annualized rate of pulmonary exacerbations when compared to placebo.

It said the drug has also met several of its pre-specified secondary endpoints with statistical significance. Based on these results, Insmed ( INSM ) plans to submit a New Drug Application with the US Food and Drug Administration for brensocatib in Q4.

If approved, the drug is expected to launch in the US by mid-2025, with Europe and Japan following in the first half of 2026, Insmed ( INSM ) said.

Insmed ( INSM ) shares rose 127% in recent premarket trading.

Price: 49.91, Change: +27.91, Percent Change: +126.86

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Pakistan's national carrier resorts to flight cancellation owing to non-payment of dues
Pakistan's national carrier resorts to flight cancellation owing to non-payment of dues
Oct 23, 2023
The airline, which was once considered the pride of Pakistan and was the first international airline to be given access to fly to Beijing, is said to be suffering millions in losses on a daily basis.
 IMF warns Europe against prematurely declaring victory over inflation
IMF warns Europe against prematurely declaring victory over inflation
Nov 8, 2023
The Washington-based IMF said that cost of underestimating inflation’s persistence could be painfully high and result in another painful round of rate hikes that could rob the economy of a large chunk of growth.
 This bank will cut bonus if employees don't come back to work
This bank will cut bonus if employees don't come back to work
Nov 22, 2023
ANZ managers have informed their respective teams about the new policy this week in generic emails, reaffirming the bank's expectation that staff devote at least half their working hours in the office each month, afr.com reported.
 Mahindra, Volvo among corporations pushing for fossil fuel exit at COP28
Mahindra, Volvo among corporations pushing for fossil fuel exit at COP28
Oct 23, 2023
Companies are increasingly committing to their own timelines for reducing their emissions, but many acknowledge that their ability to slow planet-warming CO2 emissions is contingent on faster action from governments.
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2026 - www.financetom.com All Rights Reserved